Advantech Capital logo

Advantech Capital

Asia, Hong Kong Island, Hong Kong, Central

Description

Advantech Capital is a private equity fund, focused on innovation-driven growth capital in China.

Investor Profile

Advantech Capital has made 19 investments, with 0 in the past 12 months and 47% as lead.

Stage Focus

  • Series B (47%)
  • Series A (21%)
  • Series C (11%)
  • Series D (5%)
  • Series Unknown (5%)
  • Series E (5%)
  • Post Ipo Equity (5%)

Country Focus

  • China (63%)
  • United States (37%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Medical
  • Health Care
  • Augmented Reality
  • Consumer Electronics
  • Biopharma
  • Computer
  • Artificial Intelligence (Ai)
  • Oncology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Advantech Capital frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 4
Dolby Family Ventures
North America, California, United States, San Francisco
Co-Investments: 2
Tencent
Asia, Guangdong, China, Shenzhen
Co-Investments: 4
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 2
HongShan
Asia, Beijing, China, Beijing
Co-Investments: 2
Qiming Venture Partners
Asia, Shanghai, China, Shanghai
Co-Investments: 2
CMB International Capital Corporation
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 3
Liberty Global Ventures
North America, Colorado, United States, Englewood
Co-Investments: 2
E Fund Management Co.,LTD.
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 2
Lilly Asia Ventures
Asia, Shanghai, China, Shanghai
Co-Investments: 2

Which angels does Advantech Capital often collaborate with?

Adrian Cheng
Asia, Hong Kong
Shared Deals: 1
DP
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by Advantech Capital?

Mojo Vision

Saratoga, California, United States

Mojo develops high-performance micro-LED display technology with proprietary full-color quantum-dot technology with superior performance

Augmented RealityComputerConsumer Electronics
Series AOct 12, 2023
Amount Raised: $43,500,000
Mojo Vision

Saratoga, California, United States

Mojo develops high-performance micro-LED display technology with proprietary full-color quantum-dot technology with superior performance

Augmented RealityComputerConsumer Electronics
Series BJan 4, 2022
Amount Raised: $45,000,000
Ablaze Pharmaceuticals

Jingan, Shanghai, China

Ablaze Pharmaceuticals is a clinical-stage pharmaceutical company.

BiotechnologyMedicalPharmaceutical
Series ANov 29, 2021
Amount Raised: $75,000,000
Stemirna

Beijing, Beijing, China

Stemirna Therapeutics is a RNA technology based drug development company designed to maximize the potential of RNA science.

BiotechnologyMedicalPharmaceutical
Series CJun 3, 2021
Amount Raised: $187,388,738
InventisBio

Shanghai, Shanghai, China

InventisBio is a clinical-stage biotech company dedicated to the research and development of innovative small-molecule drugs.

BiopharmaBiotechnologyPharmaceutical
Series DSep 27, 2020
Amount Raised: $147,000,000
Alphamab Oncology

Suzhou, Jiangsu, China

Alphamab Oncology is a clinical-stage biopharmaceutical company dedicated to the discovery, development manufacturing and commercialization.

BiotechnologyClinical TrialsHealth CareManufacturingOncologyPharmaceuticalTherapeutics
Series BMay 28, 2019
Amount Raised: $60,000,000
Mojo Vision

Saratoga, California, United States

Mojo develops high-performance micro-LED display technology with proprietary full-color quantum-dot technology with superior performance

Augmented RealityComputerConsumer Electronics
Series BMar 19, 2019
Amount Raised: $58,000,000
InventisBio

Shanghai, Shanghai, China

InventisBio is a clinical-stage biotech company dedicated to the research and development of innovative small-molecule drugs.

BiopharmaBiotechnologyPharmaceutical
Series CMar 12, 2019
Amount Raised: $70,000,000
AutoAI

Beijing, Beijing, China

AutoAI is an intelligent networked system developer and operator for a new generation of self-driving cars.

Automotive
Series UnknownJan 31, 2019
Amount Raised: $104,000,000
Harbour Biomed

Shanghai, Shanghai, China

Harbour BioMed is a clinical stage biopharmaceutical company developing innovative therapeutics in the fields of immuno-oncology.

BiopharmaBiotechnologyOncologyPharmaceutical
Series BAug 27, 2018
Amount Raised: $85,000,000